Clearside Biomedical (CLSD)
(Delayed Data from NSDQ)
$3.76 USD
-0.13 (-3.34%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.81 +0.05 (1.33%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Clearside Biomedical, Inc. has a market cap of $20.37M, which represents its share price of $3.89 multiplied by its outstanding shares number of 5.24M. As a small-cap company, CLSD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CLSD 3.76 -0.13(-3.34%)
Will CLSD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLSD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLSD
Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates
CLSD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates
Lineage Cell (LCTX) Reports Q1 Loss, Lags Revenue Estimates
Other News for CLSD
Is CLSD about to break its pattern? NR7 shows up after sliding 3.34%
Is CLSD positioned for a breakdown? Slingshot Bearish shows up after soaring 7.76%
Is CLSD ready to move lower? New 52 Week Low shows up after gaining 1.12%
CLSD makes New 52 Week Closing Low on September 16
CLSD makes New 52 Week Closing Low on September 15